For Release
Statement on FTC’s Win in Lawsuit Against the Makers of Dietary Supplement Prevagen
Samuel Levine, Director of the Â鶹´«Ã½ Trade Commission’s Bureau of Consumer Protection, issued the following statement on the ruling by the U.S. District Court for the Southern District of New York on the FTC and New York Attorney General’s lawsuit against the makers of the dietary supplement Prevagen. The court ordered the makers to cease making the deceptive claims challenged in the lawsuit:
“Following seven years of hard-fought litigation, including a jury trial, we are pleased that the Court has ordered Quincy Bioscience to cease making claims about Prevagen that mislead Americans concerned about memory loss. Companies should take note and remember that health claims need to be backed up by reliable scientific evidence."
This ruling is another win in the FTC’s efforts to protect older Americans. Last month, we new protections against tech support scams, which disproportionately target older consumers. Read more about out comprehensive efforts in our .
The Â鶹´«Ã½ Trade Commission works to promote competition and protect and educate consumers. The FTC will never demand money, make threats, tell you to transfer money, or promise you a prize. Learn more about consumer topics at , or report fraud, scams, and bad business practices at . Follow the FTC on social media, read and the business blog, and sign up to get the latest FTC news and alerts.